v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash Flows from Operating Activities:      
Net Income / (Loss) $ (662,200) $ (660,058)  
Depreciation and amortization 3,692 3,344  
Forgiveness of convertible note balance (85,558)    
Stock compensation expense 12,000  
Amortization of debt discount 247,369 118,189  
Attributable income per equity method - Shuya (81,638)  
Change in fair value of derivative liabilities 8,476 (1,691)  
Change in fair value of warrant liabilities 3,099 17,837 $ (370,707)
Change in fair value of convertible note receivable (Other income) (435,053)    
Reversal of inventory impairment reserve (357,639)  
(Increase) decrease in right of use asset 19,311 41,799  
(Increase) decrease in lease liability (12,762) (43,387)  
(Increase) decrease in accounts receivable 6,824 (32,226)  
(Increase) decrease in accounts receivable – related party (176,105)  
(Increase) decrease in prepaid expenses 18,466 (12,322)  
(Increase) decrease in contract asset (14,050)  
(Increase) decrease in other assets (37,040) 965  
(Increase) decrease in interest receivable (64,109)  
(Increase) decrease in inventory (63,074) 344,230  
(Decrease) increase in accounts payable 74,049 47,272  
(Decrease) increase in accrued interest 73,227 11,300  
(Decrease) increase in accrued expenses 25,188 (119,048)  
(Decrease) increase in customer deposits 43,477 125,181  
Net Cash Used In Operating Activities (836,618) (776,047)  
Cash Flows from Investing Activities      
Convertible note receivable (700,000)    
Long term investment (2,746)    
Loan receivables (2,932)  
Cash Flows Provided by (Used In) Investing Activities (702,746) (2,932)  
Cash Flows from Financing Activities      
Proceeds from notes payable and lines of credit 1,336,469 2,032,050  
Payments on notes payable and line of credit (395,451) (1,273,048)  
Stock issued for cash 34,539  
Cash Flows Provided By Financing Activities 975,557 759,002  
Foreign Currency Transaction 424 187  
Net (Decrease) Increase in Cash and Cash Equivalents (563,383) (19,790)  
Cash and Cash Equivalents at Beginning of Period 602,461 62,101 62,101
Cash and Cash Equivalents at End of Period 39,078 42,311 $ 602,461
Supplemental Cashflow Information:      
Interest Paid 21,578 116,812  
Supplemental Non-Cash Disclosure      
Discount on new notes 136,287 474,663  
Shares issued for note conversions 611,557  
Shares issued for note receivable 804,291  
Dividend accrued $ 42,751